92

News

New insulin product reflects well on Novo Nordisk financial results

Christian Wenande
August 5th, 2016


This article is more than 8 years old.

Turnover is up 5 percent over the first six months of 2016

All smiles at Novo Nordisk (photo: Novo Nordisk)

Thanks in part to its new insulin product Tresiba, the Danish biotech giant Novo Nordisk has unveiled solid half-year financial results.

The company’s turnover increased by 5 percent to 54.7 billion kroner and Tresiba had a lot to do with that success, with sales rising by 161 percent.

“Overall, we are satisfied with the performance in the first six months of 2016 in which Victoza and Tresiba continued to deliver strong sales growth and region China improved faster than expected,” said Lars Rebien Sørensen, the CEO of Novo Nordisk.

“In the USA, the market environment is becoming increasingly challenging and contract negotiations for 2017 have reflected an intensifying price competition. In spite of this, we see significant growth opportunities based on our strong diabetes care portfolio.”

READ MORE: Novo Nordisk Foundation ready to centralise diabetes treatment in Denmark

Profit up 7 percent
Overall, the firm sold diabetes medicine for 42.8 billion kroner, while the sale of other products, such as growth hormones and medication against blood disorders accounted for 11.8 billion kroner.

The net profit increased by 7 percent to 19.4 billion kroner.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”